Van Loock News Today

Researchers at the University of Stuttgart have demonstrated that a key ingredient for many quantum computation and communication schemes can be performed with an efficiency that exceeds the commonly assumed upper theoretical limit — thereby opening up new perspectives for a wide range of photonic q

Dailymirror.lk – Sri Lanka 24 Hours Online Breaking News : News, Politics, Video, Finance, Business, Sports, Entertainment, Travel, sri lanka news,sri lanka latest news, latest breaking news, latest political news, covid-19 news,covid-19 news sri lanka, Sri Lanka Coronavirus updates, sl news, sl covid-19 news, SL breaking news, daily news, breaking news in sri lanka

A pill for dengue fever developed by Johnson & Johnson JNJ.N appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company yesterday.

“It is the first ever to show antiviral activity against dengue,” said Marnix Van Loock

There are currently no specific treatments for dengue, a growing disease threat, the company said ahead of presentation of the data at the American Society of Tropical Medicine and Hygiene Annual Meeting in Chicago

Johnson & Johnson said it is testing a drug to prevent dengue that is the first antiviral to show activity against the virus, which infects millions of people each year and has no treatment.

A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday. There are currently no specific treatments for dengue, a growing disease threat, the company said ahead of presentation of the data at the American Society of Tropical Medicine and Hygiene Annual Meeting in Chicago. “It is the first ever to show ant...

10 volunteers were given a high dose of the pill 5 days before being injected with dengue

A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday.

Dengue has long been a scourge in much of Asia and Latin America, resulting in millions of infections annually and tens of thousands of deaths